Skip to main content
Caplight Logo









Biomeme

Biomeme

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://biomeme.com/

Last Round

VC Round

Dec 20, 2021

Total Funding Raised

$5.45M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Biomeme is a diagnostic equipment company that manufactures a mobile platform for real-time DNA and RNA testing outside of traditional laboratory settings.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Defense Tech, Environmental Monitoring

Business Model

B2G

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

portable PCRmolecular diagnosticspoint-of-care testingreal-time PCRbiodefense testingPOCTinfectious disease testingfield diagnosticsmachine learning diagnosticshost response testshelf-stable reagentsbacterial vs viral differentiationantibiotic stewardshipportable thermocyclerenvironmental monitoringlyophilized reagentsCBRN detectionCLIA lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biomeme Comparables

Compare Biomeme with similar companies based on industry and business-model similarity.

Biomeme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alveo Technologies
86%
Coyote Bioscience Co., Ltd.
83%
Novel Microdevices
82%

Biomeme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 20, 2021
GrantNov 30, 2021
GrantApr 9, 2021
VC RoundMar 1, 2020
SeedJan 29, 2014
Accelerator
Aug 9, 2013

Key People

Founding team and executive leadership

Max Perelman

Co-Founder President and CEO

Founding Team

Biomeme Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 33% MoM, reaching 6.4K.

  • Jun 23, 2026

    Monthly visitors increased 32% MoM.

Biomeme Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biomeme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biomeme's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range64
Year Founded2012
Last FundingDec 20, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?